Response to "CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers".
作者信息
Markova S M, Schwartz J B, Kroetz D L
机构信息
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA.
Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
出版信息
Clin Pharmacol Ther. 2014 Mar;95(3):252. doi: 10.1038/clpt.2013.239. Epub 2013 Dec 17.
PMID:24346422
Abstract
摘要
Zotero 插件